Jingjing Wu
- Cancer Research top 10%
- MicroRNA in disease regulation 3
-
- Ubiquitin and proteasome pathways 4
- Epigenetics and DNA Methylation 2
- Natural product bioactivities and synthesis 2
- RNA modifications and cancer 2
-
- Drug Transport and Resistance Mechanisms 2
- Peptidase Inhibition and Analysis 2
- Pharmacology top 10%
-
- Genetic factors in colorectal cancer 2
In The Last Decade
Jingjing Wu
19 papers receiving 655 citations
Peers
Comparison fields: 5 of 71
- Cancer Research 236
- Molecular Biology 514
- Oncology 159
- Pharmacology 89
- Pharmacology 45
Countries citing papers authored by Jingjing Wu
This map shows the geographic impact of Jingjing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingjing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingjing Wu more than expected).
Fields of papers citing papers by Jingjing Wu
This network shows the impact of papers produced by Jingjing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingjing Wu. The network helps show where Jingjing Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jingjing Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 11 | |
| 5 | 2021 | 63 | |
| 6 | 2021 | 60 | |
| 7 | 2020 | 13 | |
| 8 | 2020 | 30 | |
| 9 | 2019 | 12 | |
| 10 | 2019 | 30 | |
| 11 | 2019 | 77 | |
| 12 | 2018 | 63 | |
| 13 | 2018 | 20 | |
| 14 | 2017 | 29 | |
| 15 | 2016 | 16 | |
| 16 | 2016 | 22 | |
| 17 | 2016 | 59 | |
| 18 | 2011 | 14 | |
| 19 | 2009 | 121 | |
| 20 | 2007 | 13 |
About Jingjing Wu
Jingjing Wu is a scholar working on Cancer Research, Molecular Biology, Cell Biology, Oncology and Microbiology, having authored 20 papers that have together received 661 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), MicroRNA in disease regulation (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Epigenetics and DNA Methylation (2 papers), Genetic factors in colorectal cancer (2 papers), Natural product bioactivities and synthesis (2 papers), RNA modifications and cancer (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Cancer Research (236 citations), Molecular Biology (514 citations), Oncology (159 citations), Pharmacology (89 citations) and Pharmacology (45 citations). Jingjing Wu has collaborated with scholars based in China, Australia and Thailand. Frequent co-authors include Yuzhu Zhang, Hongfeng Chen, Meina Ye, Lina Ma, Bing Wang, Changshun Shao, Guimin Gao, Aiping Zhou, Chun Guo and Bing Xu. Their work appears in journals such as Phytochemical Analysis, Aging, Oncology Reports, Cell Death and Disease and The International Journal of Biochemistry & Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.